Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Erythrityl Tetranitrate SCHEMBL1816345 | 1.00 | ALDH1A1 (0.40) | ALDH1A1GSR | |
| Tetranitrin SCHEMBL16541075 | 1.00 | ALDH1A1 (0.40) | ALDH1A1GSR | |
| Erythrityl Tetranitrate SCHEMBL119876 | 1.00 | ALDH1A1 (0.40) | ALDH1A1GSR | |
| SCHEMBL21493267 | 0.89 | GSR (0.38) | ALDH1A1GSR | |
| SCHEMBL2957599 | 0.89 | GSR (0.38) | ALDH1A1GSR | |
| Mannitol Hexanitrate SCHEMBL220255 | 0.88 | ALDH1A1 (0.36) | ALDH1A1 | |
| Mannitol Hexanitrate SCHEMBL57515 | 0.88 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL16541089 | 0.88 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL23370731 | 0.86 | ALDH1A1 (0.34) | ALDH1A1 | |
| Erythrityl Tetranitrate SCHEMBL1269391 | 0.85 | GSR (0.36) | ALDH1A1GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 464 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12212923-B2 | First-order differential microphone array with steerable beamformer | NORTHWESTERN POLYTECHNICAL UNIVERSITY (CN) | 2025-01-28 | — | — | US | claimed |
| CN-119112554-A | Xinkang intelligent service cabin | 北京学能通科技集团有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-20260149923-A1 | AUDIO SYSTEM FOR VEHICLE | TYMPHANY HK LIMITED (HK) | 2026-05-28 | — | — | US | disclosed |
| EP-4289398-B1 | IMPROVEMENTS FOR PROSTHETIC VALVES AND RELATED INVENTIONS | TENDYNE HOLDINGS INC (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026106168-A1 | COOKING APPARATUS AND CONTROL METHOD THEREFOR | 삼성전자주식회사 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026106170-A1 | ELECTRONIC DEVICE AND CONTROL METHOD THEREOF | 삼성전자주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-20260122416-A1 | MICROPHONE ASSEMBLY AND SYSTEM ADAPTED TO FORM CONTINUOUSLY VARIABLE POLAR PATTERNS | LOGITECH EUROPE SA (CH) | 2026-04-30 | — | — | US | disclosed |
| US-20260122386-A1 | MICROPHONE ASSEMBLY ADAPTED TO FORM CONTINUOUSLY VARIABLE POLAR PATTERNS | LOGITECH EUROPE SA (CH) | 2026-04-30 | — | — | US | disclosed |
| EP-4018680-B1 | TWO-DIMENSIONAL MICROPHONE ARRAY WITH IMPROVED DIRECTIVITY | SHURE ACQUISITION HOLDINGS INC (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4710562-A1 | MULTI-DIMENSIONAL ARRAY MICROPHONE | Shure Acquisition Holdings, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12532130-B2 | Hearing device comprising a directional system configured to adaptively optimize sound from multiple target positions | OTICON A/S (DK) | 2026-01-20 | — | — | US | disclosed |
| WO-2006116499-A1 | 4-BIARYLYL-1-PHENYLAZETIDIN-2-ONE GLUCURONIDE DERIVATIVES FOR HYPERCHOLESTEROLEMIA | MICROBIA, INC. (US) | 2006-11-02 | — | — | WO | disclosed |
| WO-2006086562-A2 | PHENYLAZETIDINONE DERIVATIVES | MICROBIA, INC. (US) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006086653-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | MICROBIA, INC. (US) | 2006-08-17 | — | — | WO | disclosed |
| WO-2005112872-A1 | PEROXIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF SEXUAL DYSFUNCTION IN HUMANS | MIDWEST RESEARCH LABORATORIES, LLC (US) | 2005-12-01 | — | — | WO | disclosed |
| EP-1541175-A2 | Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions | Schering Corporation (US) | 2005-06-15 | — | — | EP | disclosed |
| CN-1582168-A | Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions | SCHERING CORP (US) | 2005-02-16 | — | — | CN | disclosed |
| EP-1385548-A2 | COMBINATIONS OF STEROL ABSORPTION INHIBITOR(S) WITH CARDIOVASCULAR AGENT(S) FOR THE TREATMENT OF VASCULAR CONDITIONS | Schering Corporation (US) | 2004-02-04 | — | — | EP | disclosed |
| US-20030069221-A1 | Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions | SCHERING CORPORATION | 2003-04-10 | — | — | US | disclosed |
| WO-2002058731-A2 | COMBINATIONS OF STEROL ABSORPTION INHIBITOR(S) WITH CARDIOVASCULAR AGENT(S) FOR THE TREATMENT OF VASCULAR CONDITIONS | SCHERING CORPORATION (US) | 2002-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12532130-B2 | Hearing device comprising a directional system configured to adaptively optimize sound from multiple target positions | HINT1, WHR1, HIRA | ALDH1A1 4211/4885GSR 2606/4885 |
| US-20260122386-A1 | MICROPHONE ASSEMBLY ADAPTED TO FORM CONTINUOUSLY VARIABLE POLAR PATTERNS | MYOC, WNT3A, MEF2D | ALDH1A1 3482/4885GSR 2610/4885 |
| US-20260122416-A1 | MICROPHONE ASSEMBLY AND SYSTEM ADAPTED TO FORM CONTINUOUSLY VARIABLE POLAR PATTERNS | MYOC, MEF2D, GJB2 | ALDH1A1 3991/4885GSR 1799/4885 |
| US-20030069221-A1 | Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions | CYP46A1, FABP2, SREBF1 | ALDH1A1 1779/4885GSR 1970/4885 |
| US-20260149923-A1 | AUDIO SYSTEM FOR VEHICLE | VRK1, GLI1, AVPR1A | ALDH1A1 1073/4885GSR 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.